PD (n=49) | |
---|---|
Age, years | 64.1 (10.1) |
Male, n (%) | 31 (63) |
Years of education | 13.9 (3.9) |
Disease duration, months | 5.3 (4.7) |
Hoehn & Yahr I & II, n (%) | 40 (81.6) |
Hoehn & Yahr III, n (%) | 9 (18.4) |
MDS–UPDRS–III | 25.6 (10.5) |
Levo–dopa dose equivalent (mg/d) | 150 (102) |
GDS–15 | 2.35 (2.27) |
MMSE | 28.9 (1.0) |
MoCA | 25.8 (3.7) |
CSF Aβ 1–40 (pg/ml) | 10716 (4859–21754)* |
CSF Aβ 1–42 (pg/ml) | 980 (404–1584)* |
*denotes range.